Free Trial

PTC Therapeutics (PTCT) Insider Trading & Ownership

PTC Therapeutics logo
$63.70 +0.05 (+0.08%)
Closing price 10/6/2026 04:00 PM Eastern
Extended Trading
$63.75 +0.05 (+0.08%)
As of 04:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PTC Therapeutics (NASDAQ:PTCT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
13
Amount Of
Insider Selling
(Last 12 Months)
$54.21M
Get PTCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling PTC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PTCT Insider Buying and Selling by Quarter

PTC Therapeutics Insider and Congressional Trades History

Transaction Date
0 Results
Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/30/2026Sell12,000$65.16$781,920.00  
9/16/2026Sell10,000$67.12$671,200.00  
9/9/2026Sell10,000$67.84$678,400.00  
8/26/2026Sell12,500$72.94$911,750.00  
8/19/2026Sell12,500$73.32$916,500.00  
8/17/2026Sell2,813$72.57$204,139.41  
8/4/2026Sell10,292$68.57$705,722.44  
7/9/2026
Mary L Smith
Director
Sell15,834$90.00$1,425,060.00  
7/9/2026Sell2,464$90.25$222,376.00  
7/7/2026Sell24,613$88.89$2,187,849.57  
7/6/2026Sell5,079$85.08$432,121.32  
7/6/2026Sell22,161$86.00$1,905,846.00  
6/26/2026Sell8,130$85.26$693,163.80  
6/25/2026Sell20,960$85.97$1,801,931.20  
6/24/2026Sell5,323$85.03$452,614.69  
6/22/2026Sell23,749$80.90$1,921,294.10  
6/17/2026Sell19,686$75.56$1,487,474.16  
6/17/2026Sell10,462$78.65$822,836.30  
6/10/2026Sell21,277$75.00$1,595,775.00  
5/15/2026Sell2,812$72.18$202,970.16  
5/14/2026Sell12,572$72.95$917,127.40  
5/8/2026Sell3,540$78.97$279,553.80  
4/21/2026Sell2,850$70.91$202,093.50  
4/6/2026Sell2,265$69.45$157,304.25  
4/2/2026Sell829$67.99$56,363.71  
4/1/2026Sell52,003$69.04$3,590,287.12  
3/12/2026Sell2,662$64.08$170,580.96  
3/10/2026Sell15,167$70.00$1,061,690.00  
3/5/2026Sell10,000$63.38$633,800.00  
3/5/2026Sell3,989$63.38$252,822.82  
3/5/2026Sell6,333$63.38$401,385.54  
2/19/2026Sell3,019$69.48$209,760.12  
2/18/2026Sell2,494$69.36$172,983.84  
2/18/2026Sell3,019$69.36$209,397.84  
2/18/2026Sell2,484$69.36$172,290.24  
2/18/2026Sell3,081$69.36$213,698.16  
2/18/2026Sell7,371$69.36$511,252.56  
2/18/2026Sell3,056$69.36$211,964.16  
2/18/2026Sell65$69.36$4,508.40  
2/18/2026Sell2,992$69.36$207,525.12  
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
2/17/2026Sell2,813$69.29$194,912.77  
1/12/2026Sell1,024$78.70$80,588.80  
1/9/2026Sell1,722$77.41$133,300.02  
1/9/2026Sell2,314$77.93$180,330.02  
1/8/2026Sell1,034$76.45$79,049.30  
1/8/2026Sell4,602$76.50$352,053.00  
1/8/2026Sell866$76.45$66,205.70  
1/8/2026Sell4,033$76.56$308,766.48  
1/8/2026Sell2,514$76.45$192,195.30  
1/8/2026Sell881$76.45$67,352.45  
1/8/2026Sell59$76.45$4,510.55  
1/7/2026Sell1,235$77.45$95,650.75  
1/7/2026Sell1,352$77.48$104,752.96  
1/7/2026Sell642$77.48$49,742.16  
1/7/2026Sell4,879$77.44$377,829.76  
1/7/2026Sell3,016$77.48$233,679.68  
1/7/2026Sell1,026$77.48$79,494.48  
1/7/2026Sell52$77.48$4,028.96  
1/6/2026Sell1,381$76.95$106,267.95  
1/6/2026Sell1,789$76.95$137,663.55  
1/6/2026Sell1,340$76.95$103,113.00  
1/6/2026Sell1,739$76.95$133,816.05  
1/6/2026Sell5,149$76.95$396,215.55  
1/6/2026Sell1,279$76.95$98,419.05  
1/6/2026Sell54$76.95$4,155.30  
1/6/2026Sell2,139$76.95$164,596.05  
1/5/2026
Emma Reeve
Emma Reeve
Director
Sell734$76.00$55,784.00  
1/5/2026Sell2,266$75.55$171,196.30  
1/2/2026Sell12,000$76.35$916,200.00  
12/30/2025Sell8,089$76.64$619,940.96  
12/19/2025Sell20,508$77.26$1,584,448.08  
12/18/2025Sell3,202$75.06$240,342.12  
12/17/2025Sell40,290$75.43$3,039,074.70  
12/3/2025
Emma Reeve
Emma Reeve
Director
Sell733$78.62$57,628.46  
12/2/2025Sell3,428$79.07$271,051.96  
11/25/2025Sell14,199$83.55$1,186,326.45  
11/25/2025Sell71,928$83.44$6,001,672.32  
11/24/2025Sell11,801$80.14$945,732.14  
11/24/2025Sell35,572$80.18$2,852,162.96  
11/21/2025
Emma Reeve
Emma Reeve
Director
Sell10,000$79.50$795,000.00  
11/17/2025Sell2,812$75.99$213,683.88  
11/12/2025
Emma Reeve
Emma Reeve
Director
Sell7,333$74.50$546,308.50  
10/30/2025
Emma Reeve
Emma Reeve
Director
Sell15,666$69.50$1,088,787.00  
10/7/2025Sell3,375$63.43$214,076.25  
(Data available from 1/1/2013 forward)

PTCT Insider Trading Activity - Frequently Asked Questions

5.30% of PTC Therapeutics stock is owned by insiders. Learn more on PTCT's insider holdings.

The following insiders have sold PTCT shares in the last 24 months: Allan Steven Jacobson ($3,142,628.29), Christine Marie Utter ($2,965,503.84), David P Southwell ($700,080.00), Emma Reeve ($5,164,024.98), Eric Pauwels ($9,887,194.53), Glenn Md Phd Steele Jr ($1,698,120.00), Jerome B Zeldis ($1,236,000.00), Lee Scott Golden ($1,200,183.86), Mark Elliott Boulding ($14,413,328.75), Mary L Smith ($1,425,060.00), Matthew B Klein ($5,286,042.77), Michael Schmertzler ($3,177,850.00), Neil Gregory Almstead ($29,732,462.03), Pierre Gravier ($555,079.33), and Stephanie Okey ($1,733,075.54).

Insiders have sold a total of 1,201,046 PTC Therapeutics shares in the last 24 months for a total of $82,316,633.92 sold.



Insider trading data for NASDAQ:PTCT was last updated on 9/30/2026, the date of the most recent reported insider or congressional trade. New trades are added as they're reported.
From Our Partners